Startup | February 22, 2022
AIIA launches ‘Ayush Start-up Challenge’
AIIA partners with Startup India with the aim to identify and support innovations and start-ups working in the Ayush sector
AIIA partners with Startup India with the aim to identify and support innovations and start-ups working in the Ayush sector
The investment in Indian clinical technology expertise in Hyderabad comes amid the clinical trials sector's move towards decentralised trials
9T Labs provides a cost-competitive solution for manufacturing that will allow structural CFRP parts to replace metals at a much faster rate in demanding applications in many sectors such as aerospace, automotive and healthcare
By connecting a leading LongBio VC to the DeSci (decentralized science) movement, this partnership is a major milestone for the greater decentralized ecosystem
Phase 2a clinical proof-of-concept biomarker study for PXL065 in ALD now anticipated to start midyear
This decision does not impact the ongoing AReSVi 006 phase III trial for RSV older adults.
The company will now be allowed to sell its proprietary and validated tinctures, gummies, and capsules across the UK
Fitch estimates JPL's EBITDA to drop significantly in FY23 due to lower volume and narrowing of the margin to 11% (FY22 estimate: 14%).
Phase 2 clinical trial to begin in 2022 with participation by Cedars Sinai Medical Center, University of Utah, and City of Hope
Nuvaxovid is the first protein-based Covid-19 vaccine authorized for use in Canada
Subscribe To Our Newsletter & Stay Updated
